Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

Abstract Background We conducted a randomized controlled trial to investigate whether an additional platelet inhibition with tirofiban would reduce the extent of myocardial damage and prevent periprocedural myonecrosis in patients with Non-ST-elevation acute coronary syndrome (NSTE-ACS) with a high...

Full description

Bibliographic Details
Main Authors: Wonjae Lee, Jung-Won Suh, Jin Joo Park, Chang-Hwan Yoon, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Glycoprotein IIb/IIIa inhibitor
Tailored antiplatelet treatment
Periprocedural myonecrosis
High residual platelet activity
Online Access:http://link.springer.com/article/10.1186/s12872-018-0938-6

Internet

http://link.springer.com/article/10.1186/s12872-018-0938-6

Similar Items